Pharmaceutical supply-chains are highly complex, with multiple owned operations, as well as significant 3rd party relationships that enable delivery of product to customers.
Each leg of the supply chain potentially carries its own ledger system creating significant complexity in data management and potential for product integrity issues. This coupled with the fact that counterfeit products cost the pharmaceutical industry $200B annually and an estimated 1% of all product in the market is counterfeit make for a costly and un-sustainable process.
BioChain Technologies, LLC was formed in October 2017 based on a recognized gap within industry for software that can support full supply chain visibility, traceability, and authentication of clients products using permissioned blockchain technology.
BioChain Technologies, through it’s proprietary BioChain software, will be first and leading innovator of pharmaceutical supply chain technology, reducing the significant costs and risks of controlling product at every point in the ecosystem.